Výsledky vyhledávání

Proliferation index as a prognostic marker in breast cancer

Autor: O Gottardi, P. Lampertico, M. Gambacorta, S. M. Veronese, F. Scanzi, Maurizio Ferrari

Publikováno v: Cancer. 71:3926-3931

Background. The proliferative activity of tumors has been extensively investigated with different approaches, among which the use of the monoclonal antibody Ki-67 represents an easy and reliable means of assessing cell proliferation. In this study, t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a9c4ad7ee3b16065919af408cee8e96
https://doi.org/10.1002/1097-0142(19930615)71:12<3926::aid-cncr2820711221>3.0.co

Zobrazit plný text záznamu

Clinical and prognostic usefulness of immunohistochemical determination of Ki67 in breast cancer

Autor: M Gambacocta, O Gottardi, F Scanzi, N Rossi, Maurizio Ferrari, Stefano Zurrida, Colombo P, M Majno, A Bono

Publikováno v: The Breast. 2:33-36

The relation between the cell proliferation marker detected by Ki67 monoclonal antibody and tumour size, node involvement, menopausal status, nuclear oestrogen receptors and disease-free survival has been analysed in 236 consecutive breast cancer pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::153f2ca15cdb92d00919ae67a9cccfb4
https://doi.org/10.1016/0960-9776(93)90034-d

Zobrazit plný text záznamu

Breast Cancer Estrogen and Progesterone Receptors: Associations with Patients' Clinical and Epidemiologic Characteristics

Autor: R. Plaino, C. Epifani, Antonio Nicolucci, F. Schittulli, T. Pedicini, G. Ambrosini, Roldano Fossati, F. Berardi, Alessandro Liberati, E. Locatelli, L. Busana, L. Armaroli, M. Indelli, M. Molteni, M. Majno, G. Gavazzini, F. Smerieri, A. Zamboni, S. Magnanini, R. Sisto, M. Biasio, D. Cosentino, Adriano Piffanelli, A. Santini, A. Rolfo, C. Poma, Silvia Marsoni, D. Palmieri, E. Aitini, A. Alexanian, O. Gottardi, G. Vaudano, G. Scognamiglio, G. Scoletta, P. Ghezzi, M. Giganti, F. Buda, G. Di Biagio, Fabio Parazzini, V. Saba, G. Marini, A. Pluchinotta, N. Monferroni, C. Confalonieri, B. Trolli, F. Testore, G. Gritti, N. Tavoni, L. Galletto, O. Nascimben, F. Peradotto, M. Monti, L. Isa, M. Rinaldini, D. Perroni, M. Braga, I. Lomonaco, P. Viola, E. Ghislandi, A. Richetti, M. R. Giolito, R. Scapaticci, M. Fumagalli

Publikováno v: Tumori Journal. 77:472-478

A total of 1095 patients with operable breast cancer and en-rolled in a randomized clinical trial were analysed for estrogen (ER) and progesterone (PgR) receptor content of their primary tumor, and the relationships between steroid receptor status an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5674fb4300d6ed86a146c6b92a11442
https://doi.org/10.1177/030089169107700605

Zobrazit plný text záznamu

Proliferation index as a prognostic marker in breast cancer

Autor: S M, Veronese, M, Gambacorta, O, Gottardi, F, Scanzi, M, Ferrari, P, Lampertico

Publikováno v: Cancer. 71(12)

The proliferative activity of tumors has been extensively investigated with different approaches, among which the use of the monoclonal antibody Ki-67 represents an easy and reliable means of assessing cell proliferation. In this study, the prolifera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::51ca5e56609a9ce5bd3931d8c0baf610
https://pubmed.ncbi.nlm.nih.gov/8508358

Zobrazit plný text záznamu

GENERAL-HOSPITAL EXPERIENCE IN TREATING NECK NODES FROM UNKNOWN PRIMARIES

Autor: Stefano Zurrida, Aldo Bono, O Gottardi, F Chiesa, Maurizio Ferrari, C Cacioppo

Publikováno v: International Journal of Oncology.

Forty cases of cervical (excluding supraclavicular) node metastases from unknown primary tumors were observed at the medical oncology department of a large general hospital. Histologically they were epidermoid carcinoma (18 cases), undifferentiated c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a002525a45be4baa06376c60a36805bb
https://doi.org/10.3892/ijo.2.4.649

Zobrazit plný text záznamu

[Clinical and prognostic usefulness of Ki67 determination in breast carcinoma]

Autor: O, Gottardi, D, Tabiadon, F, Scanzi, A, Bono, M, Majno, M, Ferrari, P, Colombo

Publikováno v: Pathologica. 84(1094)

We studied the correlation between tumor size, nodal status, menopausal status, nuclear oestrogen receptors, disease free survival and Ki67 (proliferation rate) measured by mean of immunohistochemical analysis with monoclonal antibody. Median value w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5ab3fda22aead597508db03d73aef433
https://pubmed.ncbi.nlm.nih.gov/1300528

Zobrazit plný text záznamu

Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer)

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 2(9)

Summary In a multicentre Phase III trial, 182 patients were randomized to either folinic acid (FA) (200 mg/sqm i.v. × 5 days) + 5-fluorouracil (5-FU) (400 mg/sqm i.v. in 15' × 5 days) every 4 weeks (Arm A), or to 5-FU one at the same dosage (Arm B)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73efb74ef5945c14bd5303cabf6c27a0
https://pubmed.ncbi.nlm.nih.gov/1742223

Zobrazit plný text záznamu

Correlation between histochemically assessed hormonal receptor content and clinical course in breast cancer. Presentation of 1,005 cases

Autor: O, Gottardi, C, Baiocchi, M, Ferrari, L, Franchi, M, Gambacorta, G, Landonio, N, Pinna, E, Ghislandi

Publikováno v: Oncology. 48(3)

Lee's histochemical method was used to assess hormonal receptors in 1,005 patients with breast cancer. Patients were from 8 oncological departments in northern Italy. The group was subdivided into four subgroups in relation to menopausal status and p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a6b270d394878cf8d6b1ad4d6ea06b14
https://pubmed.ncbi.nlm.nih.gov/2023701

Zobrazit plný text záznamu

Impact of Follow-up Testing on Survival and Health-Related Quality of Life in Breast Cancer Patients

Autor: F. Berardi, A. Pluchinotta, C. Epifani, M. Braga, C. D'Amico, P. Zola, S. Magnanini, M. Biasio, P. Viola, Enrico Aitini, D. Cosentino, F. Schittulli, N. Monferroni, Alessandro Liberati, F. Testare, B. Trolli, R. Grilli, M. Monti, G. Papaccio, M. C. Liberati, M. Fumagalli, M. Sussio, Alberto Zaniboni, D. Perroni, A. Santini, O. Gottardi, M. Indelli, A. Rolfo, E. Ghislandi, F. Smerieri, A. Alexanian, G. Vaudano, M. R. Giolito, B. E. Meyerowitz, G. Di Biagio, G. Cavazzini, G. Marini, O. Nascimben, F. Peradotto, C. Confalonieri, G. Gritti, Adriano Piffanelli, Silvia Marsoni, B. Salvadori, M. Majno, L. Busana, L. Armaroli, E. Marubini, Valter Torri, L. Isa, M. Rinaldini, Antonio Nicolucci, T. Pedicini, E. Locatelli, Giovanni Apolone, Paola Mosconi, A. Richetti, Gianni Tognoni, R. Busolin, P. Ghezzi, N. Tavoni, G. Gini, L. Galletto, Roldano Fossati, M. Molteni, G. Ambrosini

Publikováno v: JAMA. 271:1587

Objective. —To assess prospectively the impact on survival and health-related quality of life of two follow-up protocols in patients with early breast cancer. Design. —Randomized controlled clinical trial. Setting. —Multicenter study involving

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::99a2de9f614b77c2ff1455e1e0c13f0b
https://doi.org/10.1001/jama.1994.03510440047031

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání